beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression

M C Irizarry1, J J Locascio, B T Hyman

  • 1Alzheimer Disease Research Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.

Insights

This study investigated amyloid precursor protein (APP) and beta-site APP cleaving enzyme (BACE) expression in transgenic mouse models. Findings show APP and BACE are expressed in similar brain regions, facilitating amyloid-beta formation, but influenced by age and anatomy.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Beta-site APP cleaving enzyme (BACE) is key for amyloid precursor protein (APP) cleavage in the brain.
  • Understanding APP and BACE expression is crucial for Alzheimer's disease research.

Purpose of the Study:

  • To examine human APP (hAPP) and BACE mRNA expression in young and old hAPP transgenic mice.
  • To correlate gene expression patterns with amyloid deposition in different brain regions.

Main Methods:

  • In situ hybridization was used to analyze hAPP and BACE mRNA expression in Tg2576 and PDAPP transgenic mouse models.
  • Amyloid burden was quantified in various brain areas of the transgenic mice.
  • Emulsion-dipped sections were utilized to confirm neuronal expression patterns.

Main Results:

  • hAPP expression was highest in cortical, cerebellar, and hippocampal neurons in transgene-positive mice.
  • Amyloid burden was observed in the cingulate, entorhinal, and hippocampal regions, but not the cerebellum.
  • BACE expression showed a predominantly neuronal pattern, with highest levels in the cerebellum and hippocampus, independent of age or transgene presence.

Conclusions:

  • hAPP and endogenous BACE expression in overlapping neuronal populations facilitate APP processing and amyloid-beta formation in transgenic models.
  • Age-related and anatomical factors modulate amyloid-beta production, suggesting complex disease mechanisms.

Related Concept Videos